Literature DB >> 7141706

Increased severity of urinary tract infection and bacteremia in mice with urinary bladder injury induced by cyclophosphamide.

D Lyon, E B Howard, J Z Montgomerie.   

Abstract

The effect of cyclophosphamide on urinary tract infection was studied, using Pseudomonas aeruginosa in a murine model. Urinary tract infections were produced by injecting P. aeruginosa through a urethral catheter into the bladders of mice. The number of P. aeruginosa organisms in the bladder tissue and kidneys, histopathology, peripheral leukocyte count, and antibody response to P. aeruginosa was measured. The local effect of cyclophosphamide on the bladder was determined by measuring the bladder tissue water and examining the histopathology. Cyclophosphamide increased the susceptibility of mice to P. aeruginosa urinary tract infection, resulting in marked cystitis and an increase in renal infection, bacteremia, and mortality. These changes correlated with the toxic effect of cyclophosphamide on the wall of the bladder rather than with peripheral leukopenia or failure of antibody response.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7141706      PMCID: PMC347775          DOI: 10.1128/iai.38.2.558-562.1982

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  8 in total

1.  Effect of N-acetylcysteine on some aspects of cyclophosphamide-induced toxicity and immunosuppression.

Authors:  L Levy; R Harris
Journal:  Biochem Pharmacol       Date:  1977-06-01       Impact factor: 5.858

2.  Cyclophosphamide and urinary bladder toxicity.

Authors:  F S PHILIPS; S S STERNBERG; A P CRONIN; P M VIDAL
Journal:  Cancer Res       Date:  1961-12       Impact factor: 12.701

3.  Urinary-bladder fibrosis and telangiectasia associated with long-term cyclophosphamide therapy.

Authors:  W W Johnson; D C Meadows
Journal:  N Engl J Med       Date:  1971-02-11       Impact factor: 91.245

4.  Hemorrhagic cystitis and cytomegalic inclusions in the bladder associated with cyclophosphamide therapy.

Authors:  R L Goldman; N E Warner
Journal:  Cancer       Date:  1970-01       Impact factor: 6.860

5.  Enzyme-linked immunosorbent assays for cholera serology.

Authors:  J Holmgren; A M Svennerholm
Journal:  Infect Immun       Date:  1973-05       Impact factor: 3.441

Review 6.  Hematologic malignancies and other marrow failure states: progress in the management of complicating infections.

Authors:  A S Levine; S C Schimpff; R G Graw; R C Young
Journal:  Semin Hematol       Date:  1974-04       Impact factor: 3.851

7.  Cyclophosphamide cystitis--identification of acrolein as the causative agent.

Authors:  P J Cox
Journal:  Biochem Pharmacol       Date:  1979-07-01       Impact factor: 5.858

8.  Pseudomonas urinary tract infection in mice.

Authors:  J Z Montgomerie; W J Tuddenham; E B Howard; J W Morrow
Journal:  Infect Immun       Date:  1980-07       Impact factor: 3.441

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.